Pharmaceutical giants Sanofi and Regeneron have expanded their collaboration through a new $8 billion drug development agreement. The deal also marks the resolution of existing legal disputes between the two companies. Following the announcement, Sanofi shares saw an increase of nearly 1% at Thursday's market close. Conversely, shares of the Tarrytown, New York-based firm Regeneron experienced a 4% decline during midday trading.
অর্থনীতি
Sanofi and Regeneron ink $8 billion drug development deal, resolve legal dispute
Sanofi and Regeneron have entered into an $8 billion drug development partnership while simultaneously settling their ongoing legal disputes.
তথ্যসূত্র: The Business Standard